RxDoctor Payments Data

Farhan Taghizadeh, MD

Otolaryngology · Phoenix, AZNPI 1114948353

Payments from drug & device makers

What this record shows

The money is spread across several categories — gifts (31.3%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Aerin Medical Inc. at 40.5% of the total. Reporting peaked in 2020 at $15,169 and has fallen 84.3% since, to $2,379 in 2025. Among otolaryngology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,854in general payments, 2019–2025

Across 213 payments — averaging $215.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$19K
  • AbbVie$14K
  • Merz North America, Inc.$9K
  • Medtronic$2K
  • Stryker$951
  • Galderma Laboratories, L.p.$443
  • plus $1K from 12 others
$17,710in research payments, 2019–2025

Across 4 payments — averaging $4427.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$18K

What the payments were for

  • Consulting fees$12,40027%
  • Speaking & faculty fees$8,15018%
  • Travel & lodging$4,2119%
  • Food & beverage$6,70415%
  • Education$170%
  • Gifts$14,37231%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,854 in reported general payments places this provider in the 95th percentile of 150 otolaryngology providers in Arizona.

See all otolaryngology providers in Arizona

Medicare billing

Part B allowed, 2024
$131,993
Medicare patients
290
Services billed
841

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide67$1,497
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen68$497
Amoxicillin67$203
Mupirocin23$123
Ciprofloxacin Hcl21$115
Omeprazole16$100
Cephalexin21$97
Clindamycin Hcl18$75
Acyclovir11$20

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →